No advertising of pharmaceutical drugs or sponsors on the website of the Foundation for bipolar children and adolescents has been renamed to the Zen way "Foundation mental balance." (Meditation and medication are the same thing, no?)Instead, visitors to the site will find treacherous stories of children saved from bipolar medications and a list of donor families. But according to the Journal of the American Academy of Child and Adolescent Psychiatry current trends that the Foundation uses to distinguish bipolar disorder in children and adolescents were funded by Abbott, AstraZeneca, Eli Lilly, Forest, Janssen, Novartis, and Pfizer. Oops. The American Academy of Child and Adolescent Psychiatry, the group that produces the Journal, is also seen as a possible front organization for Pharma. The magazine is the same in which he appeared "Studio 329" on Paxil who buried dell'antidepressivo the risk of suicide in adolescents. The prosecution brought by the Attorney General of New York in 2004 showed that the search was not even written by the doctors and researchers who twenty-two listed, but (hear hear) from the company's marketing GlaxoSmithKline. Everything, including the scientific and therapeutic. The authors of the influential guidelines in 2007 for children of the Journal of the American Academy of Child & Adolescent Psychiatry, according to which "sometimes it is necessary to use drugs," although they had financial links with Abbott, AstraZeneca, Boehringer-Ingelheim, Bristol -Myers Squibb, Cephalon, Eli Lilly, Forest Labs, GlaxoSmithKline (GSK), various divisions of Johnson & Johnson and ten other drug companies. In 2012, the Academy has only received $ 221,000 from Eli Lilly for research and conferences.Nothing less. "Children are forced by school personnel to take their medications," says Gwen Olsen, author of "Confessions of a drug pusher." "They are forced by their parents and their doctors to take these drugs. Thus, children are the patient type ideal for 'longevity' and because the drug is imposed on them."Another widely viewed as a front group for Pharma is the American Foundation for Suicide Prevention, dedicated to combating suicide caused by lack of drugs we provide. Suicide prevention is a basic tool of marketing for Pharma. What they do not tell you is that, despite the sales of antidepressants have increased by 400% in the wake of their terrorist campaigns, suicide not only unabated, but rather worrying increase in proportion: 36,000 deaths per year.Nothing less. The American Foundation for Suicide Prevention has received $ 100,000 from Eli Lilly in 2011 and $ 50,000 in 2012 and has been driven for a long time psychiatrist Charles Nemeroff, thrown out of the Emory University after Congress discovered secret payments from the Pharma Emory for at least $ 1.2 million. Nothing less. According to the medical journal UIC in Spring 2008 Pharma gave between $ 10,000 and $ 24,000 at the Faculty of Medicine of the University of Illinois at Chicago, along with GSK, maker of Paxil.Another group uncertain is the National Council for behavioral health care to the community, described on its website as "a non-profit organization representing 1,300 mental health and addiction treatment and rehabilitation." However receives donations of at least half a million dollars from Pharma. In 2010, the Council received $ 190,000 from Eli Lilly and $ 500,000 from AstraZeneca. Nice work without profit, if you can say. According to his own magazine last year the group has received funding from AstaZeneca and Bristol-Myers Squibb. No wonder the Council pushes in his magazine National Council the "week of awareness of mental illness, suicide prevention" and profitable idea that addiction is "a chronic medical condition treatable, like diabetes or heart disease." Already.Finally, there is the American Professional Society of ADHD and Related Disorders (APSARD), the first international organization based in the United States to focus exclusively on ADHD. "The APSARD offer a range of services including a complete Web site, an annual scientific meeting, a quarterly magazine and the development of guidelines to address the diagnosis, assessment and treatment of ADHD throughout the life span," this promises his first press release without mentioning that Eli Lilly will fund the newsletter and the 2010 conference. Oops. In addition to funds from Pharma, many psychiatrists are able to smooth their income by prescribing medications that their patients - adults and children - may not even need. A psychiatrist who works eight hours a day doing therapy communication "earns about $ 940 a day, $ 4,700 a week and $ 225,000 per year," according to an article entitled, "The Industrialized, New-Deal Age of Psychiatry" by psychiatrist Ronald Ricker. So much effort for so little? "Much better to their patients monthly monitoring visits lasting 15 minutes - each paid about $ 90," says Ricker. "Multiply forty patients a day and add a few extras ... et voila the momentum built over a million dollars a year." Nothing less. The pill that lays golden eggs is backed by fake illness and support groups of patients funded by Pharma. Evelyn Pringle is an investigative journalist and a pharmaceutical researcher.
Martha Rosenberg is an investigative reporter who takes care of health and author of the book "Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health" (Prometheus Books)
Nessun commento:
Posta un commento